These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17446305)

  • 1. Giving APCmin tumours a SPARC.
    Gregorieff A; Clevers H
    Gut; 2007 Oct; 56(10):1341-3. PubMed ID: 17446305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumorigenesis: TCF4 feeds c-Jun.
    Raftopoulou M
    Nat Cell Biol; 2005 Oct; 7(10):932. PubMed ID: 16195746
    [No Abstract]   [Full Text] [Related]  

  • 3. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficiency of SPARC suppresses intestinal tumorigenesis in APCMin/+ mice.
    Sansom OJ; Mansergh FC; Evans MJ; Wilkins JA; Clarke AR
    Gut; 2007 Oct; 56(10):1410-4. PubMed ID: 17299058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myh deficiency enhances intestinal tumorigenesis in multiple intestinal neoplasia (ApcMin/+) mice.
    Sieber OM; Howarth KM; Thirlwell C; Rowan A; Mandir N; Goodlad RA; Gilkar A; Spencer-Dene B; Stamp G; Johnson V; Silver A; Yang H; Miller JH; Ilyas M; Tomlinson IP
    Cancer Res; 2004 Dec; 64(24):8876-81. PubMed ID: 15604247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of Apc+ in intestinal adenomas from Min mice.
    Luongo C; Moser AR; Gledhill S; Dove WF
    Cancer Res; 1994 Nov; 54(22):5947-52. PubMed ID: 7954427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
    Li Q; Ishikawa TO; Oshima M; Taketo MM
    Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cooperation between the thyroid hormone receptor TRalpha1 and the WNT pathway in the induction of intestinal tumorigenesis.
    Kress E; Skah S; Sirakov M; Nadjar J; Gadot N; Scoazec JY; Samarut J; Plateroti M
    Gastroenterology; 2010 May; 138(5):1863-74. PubMed ID: 20114049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-17F deficiency inhibits small intestinal tumorigenesis in ApcMin/+ mice.
    Chae WJ; Bothwell AL
    Biochem Biophys Res Commun; 2011 Oct; 414(1):31-6. PubMed ID: 21939640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanylyl cyclase C suppresses intestinal tumorigenesis by restricting proliferation and maintaining genomic integrity.
    Li P; Schulz S; Bombonati A; Palazzo JP; Hyslop TM; Xu Y; Baran AA; Siracusa LD; Pitari GM; Waldman SA
    Gastroenterology; 2007 Aug; 133(2):599-607. PubMed ID: 17681179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. APC and intestinal carcinogenesis. Insights from animal models.
    Bertagnolli MM
    Ann N Y Acad Sci; 1999; 889():32-44. PubMed ID: 10668480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of the WNT target and cancer stem cell marker CD44 in Apc(Min/+) mice attenuates intestinal tumorigenesis.
    Zeilstra J; Joosten SP; Dokter M; Verwiel E; Spaargaren M; Pals ST
    Cancer Res; 2008 May; 68(10):3655-61. PubMed ID: 18483247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice.
    Kongkanuntn R; Bubb VJ; Sansom OJ; Wyllie AH; Harrison DJ; Clarke AR
    Oncogene; 1999 Dec; 18(51):7219-25. PubMed ID: 10602475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In utero and neonatal sensitivity of ApcMin/+ mice to radiation-induced intestinal neoplasia.
    Ellender M; Harrison JD; Kozlowski R; Szłuińska M; Bouffler SD; Cox R
    Int J Radiat Biol; 2006 Mar; 82(3):141-51. PubMed ID: 16638711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta receptor type II inactivation induces the malignant transformation of intestinal neoplasms initiated by Apc mutation.
    Muñoz NM; Upton M; Rojas A; Washington MK; Lin L; Chytil A; Sozmen EG; Madison BB; Pozzi A; Moon RT; Moses HL; Grady WM
    Cancer Res; 2006 Oct; 66(20):9837-44. PubMed ID: 17047044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatic mutational mechanisms involved in intestinal tumor formation in Min mice.
    Shoemaker AR; Luongo C; Moser AR; Marton LJ; Dove WF
    Cancer Res; 1997 May; 57(10):1999-2006. PubMed ID: 9157997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MSH2 deficiency contributes to accelerated APC-mediated intestinal tumorigenesis.
    Reitmair AH; Cai JC; Bjerknes M; Redston M; Cheng H; Pind MT; Hay K; Mitri A; Bapat BV; Mak TW; Gallinger S
    Cancer Res; 1996 Jul; 56(13):2922-6. PubMed ID: 8674041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between murine germline mutations in p53 and APC predisposes to pancreatic neoplasia but not to increased intestinal malignancy.
    Clarke AR; Cummings MC; Harrison DJ
    Oncogene; 1995 Nov; 11(9):1913-20. PubMed ID: 7478622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are intestinal tumours in Apc+/-mice a suitable model of colorectal carcinoma in man?
    Lojda Z; Havránková E; Sovová V; Sloncová E; Fric P
    Gen Physiol Biophys; 1999 Sep; 18(3):311-6. PubMed ID: 10703747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The significance of the extracellular matrix for carcinogenesis in the intestinal tract].
    Stallmach A; Schuppan D; Riecken EO
    Dtsch Med Wochenschr; 1990 Mar; 115(12):467-72. PubMed ID: 2180668
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.